BASFs, Pipeline

BASF's Pipeline Promises Meet a Skeptical Market

Published on 11/22/2026 at 12:31 | Editorial boerse-global.de
BASF touts biodegradable mulch films and Nemasphere soy tech while shares slide 9% over seven sessions and analysts split after Evonik talks collapse.
BASFs, Pipeline, Promises, Meet, Skeptical, Market, BASF, Nemasphere, Evonik Illustration mit AI erstellt.

BASF used the closing days of a turbulent week to remind investors that its product pipeline is still moving. On Friday the Ludwigshafen-based chemicals group said its biodegradable biopolymer ecovio is supporting the development of soil-biodegradable mulch films that comply with EU Regulation 2019/1009. The announcement landed against a rough backdrop: the stock shed 2.6% on Friday to close at €49.45 and has lost 9.0% over the past seven sessions.

The weakness was not company-specific. German chemical shares came under broad pressure, with dpa-AFX pointing to soft US market leads and a wave of analyst downgrades, chiefly at Lanxess and Evonik. For BASF, the more consequential news had arrived a day earlier, when it walked away from its pursuit of Evonik after the specialty chemicals maker rejected two non-binding all-cash offers. Management concluded that a higher valuation was not justified given Evonik's standalone prospects and risks. Reuters reported that BASF shares initially rose by as much as 2.8% on the withdrawal.

Two Very Different Yardsticks for the Growth Story

The ecovio update is a development milestone, not a revenue event. Regulatory suitability would be one building block for the films, but it says nothing yet about their commercial uptake. What matters for the equity story is the next step: whether use in development translates into demand, then orders, and finally into sales.

BASF's agricultural technology Nemasphere offers a firmer yardstick. The company announced worldwide marketing of the technology on 16 November, with corresponding soybean varieties slated to reach the US and Brazilian markets from 2028. That planned launch date gives investors something the mulch-film news does not — a timeline they can actually hold the company to.

Should investors sell immediately? Or is it worth buying BASF?

BASF pegs Nemasphere's peak sales potential at more than €300 million. That figure is neither a forecast for the launch year nor a profit target. In a favourable scenario, the entry into both countries goes ahead as scheduled and demand builds from there, allowing the stated potential to be checked against actual volumes. Delays would push the expected contribution further into the future — and even an on-time launch could underwhelm economically if the soybean varieties spread more slowly than hoped. A large peak-sales number says little about how quickly BASF could get there.

Divestment and Downgrades

Alongside the pipeline news, BASF signed an agreement on 12 November to sell its mining solutions business to SNF. Completion is expected in 2027, subject to merger-control clearance from the relevant authorities and customary closing conditions.

Analyst sentiment remains split. Jefferies cut BASF to "Underperform" from "Hold" on 11 November, keeping its €44 price target. Analyst Priyanka Patel cited shrinking margins, overcapacity, higher gas prices and a lack of recovery in demand. Bernstein Research, by contrast, reaffirmed "Outperform" with a €59 target on Thursday, after the Evonik talks collapsed. Those opposing verdicts are not forecasts for Nemasphere or ecovio, but they illustrate why a single product announcement should not be mistaken for a re-rating of the whole stock. That would require the economic contribution of the products to become clearer.

What to Watch on 24 November

The next fixed date on the calendar is BASF's Capital Markets Day on 24 November. The most useful takeaway for investors would be a sharper classification of the marketing steps — clarity on which product opportunities can already be placed on a timeline, and which will only gain weight once a commercial application emerges. For ecovio, the signal that could shift the perspective is the transition from film development to commercial use; for Nemasphere, it is whether the company sticks to its planned market entry.

Ad

BASF Stock: New Analysis - 22 November

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

Disclaimer...
en | DE000BASF111 | BASFS | boerse | 70544205 |